Press "Enter" to skip to content

New patent expiration for Novo Nordisk drug NOVOLOG

0

Annual Drug Patent Expirations for NOVOLOG
Annual Drug Patent Expirations for NOVOLOG

Novolog is a drug marketed by Novo Nordisk Inc
and is included in three NDAs. It is available from three suppliers. There are sixteen patents protecting this drug.

The generic ingredient in NOVOLOG is insulin aspart protamine recombinant; insulin aspart recombinant. Three suppliers are listed for this compound. Additional details are available on the insulin aspart protamine recombinant; insulin aspart recombinant profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs,
contact admin@DrugPatentWatch.com
or visit www.DrugPatentWatch.com

Do NOT follow this link or you will be banned from the site!